Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.
This resource summarizes discussions from a 2019 National Institutes of Health consensus meeting on Postural Orthostatic Tachycardia Syndrome (POTS), focusing on current understanding, diagnosis, and management. POTS is characterized by orthostatic intolerance and increased heart rate without hypotension, often accompanied by fatigue and gastrointestinal issues. The condition is most common in young women and can be triggered by factors like viral infections. The pathophysiology is complex and not fully understood. Diagnosis involves excluding other conditions, and management starts with education and non-pharmacological strategies, as there are no FDA-approved medications for POTS. This article emphasizes the multifaceted approach required for optimal care.
Published June 20, 2021
Contributors
- Dr. Steven Vernino
- Kate M Bourne
- Lauren E. Stiles, JD
- Dr. Blair P. Grubb, MD
- Dr. Artur Fedorowski
- Julian M Stewart
- Amy C Arnold
- Dr. Laura Pace
- Jonas Axelsson
- Dr. Jeffrey R. Boris
- Jeffrey P. Moak, MD
- Dr. Brent Goodman, MD
- Dr. Kamal R. Chemali
- Tae H Chung
- David S Goldstein
- Andre Diedrich
- Dr. Mitchell G. Miglis, MD
- Melissa M Cortez
- Amanda J Miller
- Roy Freeman
- Italo Biaggioni
- Peter C Rowe
- Robert S Sheldon
- Dr. Cyndya A. Shibao
- David M Systrom
- Glen A. Cook, MD
- Taylor A Doherty
- Hasan I Abdallah
- Anil Darbari
- Dr. Satish R. Raj, MD, MSCI